Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Spanlastics are effective for delivering Meloxicam with improved stability and targeting.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Men with better urinary symptoms have a lower risk of death.